Heparin normalizes allergen-induced nitric oxide deficiency and airway hyperresponsiveness

British Journal of Pharmacology

Volumn 142, Issue 8, 2004, Pages 1293-1299

  Maarsingh, Harm ^a   De Boer, Jacob ^a   Kauffman, Henk F ^b   Zaagsma, Johan ^a   Meurs, Herman ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Airway hyperresponsiveness; Allergic asthma; Cationic amino acid transporter; Early asthmatic reaction; Eosinophils; Guinea pig; Heparin; L Arginine; Nitric oxide synthase; Polycations

Indexed keywords

ALLERGEN; HEPARIN; METHACHOLINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; OVALBUMIN; POLYCATION;

AIRWAY; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS HYPERREACTIVITY; CELL INFILTRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EOSINOPHIL; EXPERIMENTAL MODEL; GUINEA PIG; HYPOTHESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROVOCATION TEST; TRACHEA;

ALLERGENS; ANIMALS; BRONCHIAL HYPERREACTIVITY; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; HEPARIN; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE;

EID: 4444318121     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705848     Document Type: Article

References (41)

1. AALBERS, R., KAUFFMAN, H.F., VRUGT, B., KOETER, G.H. & DE MONCHY, J.G. (1993). Allergen-induced recruitment of inflammatory cells in lavage 3 and 24 h after challenge in allergic asthmatic lungs. Chest, 103, 1178-1184.
2. AHMED, T., CAMPO, C., ABRAHAM, M.K., MOLINARI, J.F., ABRAHAM, W.M., ASHKIN, D., SYRISTE, T., ANDERSSON, L.O. & SVAHN, C.M. (1997). Inhibition of antigen-induced acute bronchoconstriction, airway hyperresponsiveness, and mast cell degranulation by a nonanticoagulant heparin: comparison with a low molecular weight heparin. Am. J. Respir. Crit. Care Med., 155, 1848-1855.
3. AHMED, T., GARRIGO, J. & DANTA, I. (1993). Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin. N. Engl. J. Med., 329, 90-95.
4. AHMED, T., SYRISTE, T., MENDELSSOHN, R., SORACE, D., MANSOUR, E., LANSING, M., ABRAHAM, W.M. & ROBINSON, M.J. (1994). Heparin prevents antigen-induced airway hyperresponsiveness: interference with IP3-mediated mast cell degranulation? J. Appl. Physiol., 76, 893-901.
5. AHMED, T., UNGO, J., ZHOU, M. & CAMPO, C. (2000). Inhibition of allergic late airway responses by inhaled heparin-derived oligosaccharides. J. Appl. Physiol., 88, 1721-1729.
6. BOWLER, S.D., SMITH, S.M. & LAVERCOMBE, P.S. (1993). Heparin inhibits the immediate response to antigen in the skin and lungs of allergic subjects. Am. Rev. Respir. Dis., 147, 160-163.
7. CEYHAN, B. & CELIKEL, T. (1995). Effect of inhaled heparin on methacholine-induced bronchial hyperreactivity. Chest, 107, 1009-1012.
8. CEYHAN, B.B. & CELIKEL, T. (2000). Effect of inhaled low molecular weight heparin on methacholine-induced bronchoconstriction. Int. J. Clin. Pharmacol. Ther., 38, 446-451.
9. CHILVERS, E.R., CHALLISS, R.A., WILLCOCKS, A.L., POTTER, B.V., BARNES, P.J. & NAHORSKI, S.R. (1990). Characterisation of stereospecific binding sites for inositol 1,4,5-trisphosphate in airway smooth muscle. Br. J. Pharmacol., 99, 297-302.
10. CLOSS, E.I. (1996). CATs, a family of three distinct mammalian cationic amino acid transporters. Amino Acids, 11, 193-208.
11. COYLE, A.J., ACKERMAN, S.J. & IRVIN, C.G. (1993). Cationic proteins induce airway hyperresponsiveness dependent on charge interactions. Am. Rev. Respir. Dis., 147, 896-900.
12. DE BOER, J., DUYVENDAK, M., SCHUURMAN, F.E., POUW, F.M., ZAAGSMA, J. & MEURS, H. (1999). Role of L-arginine in the deficiency of nitric oxide and airway hyperreactivity after the allergen-induced early asthmatic reaction in guinea-pigs. Br. J. Pharmacol., 128, 1114-1120.
13. DE BOER, J., MEURS, H., COERS, W., KOOPAL, M., BOTTONE, A.E., VISSER, A.C., TIMENS, W. & ZAAGSMA, J. (1996). Deficiency of nitric oxide in allergen-induced airway hyperreactivity to contractile agonists after the early asthmatic reaction: an ex vivo study. Br. J. Pharmacol., 119, 1109-1116.
14. DIAMANT, Z., TIMMERS, M.C., VAN, D.V., PAGE, C.P., VAN DER MEER, F.J. & STERK, P.J. (1996). Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma. Am. J. Respir. Crit. Care Med., 153, 1790-1795.
15. FRYER, A.D. & JACOBY, D.B. (1992). Function of pulmonary M2 muscarinic receptors in antigen-challenged guinea pigs is restored by heparin and poly-L-glutamate. J. Clin. Invest., 90, 2292-2298.
16. FRYER, A.D. & JACOBY, D.B. (1998). Muscarinic receptors and control of airway smooth muscle. Am. J. Respir. Crit. Care Med., 158, S154-S160.
17. GARRIGO, J., DANTA, I. & AHMED, T. (1996). Time course of the protective effect of inhaled heparin on exercise-induced asthma. Am. J. Respir. Crit. Care Med., 153, 1702-1707.
18. GHOSH, T.K., EIS, P.S., MULLANEY, J.M., EBERT, C.L. & GILL, D.L. (1988). Competitive, reversible, and potent antagonism of inositol 1,4,5-trisphosphate-activated calcium release by heparin. J. Biol. Chem., 263, 11075-11079.
19. GLEICH, G.J., ADOLPHSON, C.R. & LEIFERMAN, K.M. (1993). The biology of the eosinophilic leukocyte. Annu. Rev. Med., 44, 85-101.
20. HALAYKO, A.J., RECTOR, E. & STEPHENS, N.L. (1998). Airway smooth muscle cell proliferation: characterization of subpopulations by sensitivity to heparin inhibition. Am. J. Physiol., 274, L17-L25.
21. HAMMERMANN, R., HIRSCHMANN, J., HEY, C., MOSSNER, J., FOLKERTS, G., NIJKAMP, F.P., WESSLER, I. & RACKE, K. (1999). Cationic proteins inhibit L-arginine uptake in rat alveolar macrophages and tracheal epithelial cells. Implications for nitric oxide synthesis. Am. J. Respir. Cell Mol. Biol., 21, 155-162.
22. LERNER, L. & TORCHIA, D.A. (1986). A multinuclear NMR study of the interactions of cations with proteoglycans, heparin, and ficoll. J. Biol. Chem., 261, 12706-12714.
23. LUCIO, J., D'BROT, J., GUO, C.B., ABRAHAM, W.M., LICHTENSTEIN, L.M., KAGEY-SOBOTKA, A. & AHMED, T. (1992). Immunologic mast cell-mediated responses and histamine release are attenuated by heparin. J. Appl. Physiol., 73, 1093-1101.
24. MEURS, H., HAMER, M.A., PETHE, S., VADON-LE GOFF, S., BOUCHER, J.L. & ZAAGSMA, J. (2000). Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activity. Br. J. Pharmacol., 130, 1793-1798.
25. MEURS, H., MAARSINGH, H. & ZAAGSMA, J. (2003). Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness. Trends Pharmacol. Sci., 24, 450-455.
26. MEURS, H., MCKAY, S., MAARSINGH, H., HAMER, M.A., MACIC, L., MOLENDIJK, N. & ZAAGSMA, J. (2002). Increased arginase activity underlies allergen-induced deficiency of cNOS-derived nitric oxide and airway hyperresponsiveness. Br. J. Pharmacol., 136, 391-398.
27. MEURS, H., SCHUURMAN, F.E., DUYVENDAK, M. & ZAAGSMA, J. (1999). Deficiency of nitric oxide in polycation-induced airway hyperreactivity. Br. J. Pharmacol., 126, 559-562.
28. MOLINARI, J.F., CAMPO, C., SHAKIR, S. & AHMED, T. (1998). Inhibition of antigen-induced airway hyperresponsiveness by ultralow molecular-weight heparin. Am. J. Respir. Crit. Care Med., 157, 887-893.
29. MOTOJIMA, S., FRIGAS, E., LOEGERING, D.A. & GLEICH, G.J. (1989). Toxicity of eosinophil cationic proteins for guinea-pig tracheal epithelium in vitro. Am. Rev. Respir. Dis., 139, 801-805.
30. RICCIARDOLO, F.L., TIMMERS, M.C., GEPPETTI, P., VAN SCHADEWIJK, A., BRAHIM, J.J., SONT, J.K., DE GOUW, H.W., HIEMSTRA, P.S., VAN KRIEKEN, J.H. & STERK, P.J. (2001). Allergen-induced impairment of bronchoprotective nitric oxide synthesis in asthma. J. Allergy Clin. Immunol., 108, 198-204.
31. SANTING, R.E., HOEKSTRA, Y., PASMAN, Y., ZAAGSMA, J. & MEURS, H. (1994a). The importance of eosinophil activation for the development of allergen-induced bronchial hyperreactivity in conscious, unrestrained guinea-pigs. Clin. Exp. Allergy, 24, 1157-1163.
32. SANTING, R.E., MEURS, H., VAN DER MARK, T.W., REMIE, R., OOSTEROM, W.C., BROUWER, F. & ZAAGSMA, J. (1992). A novel method to assess airway function parameters in chronically instrumented, unrestrained guinea-pigs. Pulmon. Pharmacol., 5, 265-272.
33. SANTING, R.E., OLYMULDER, C.G., ZAAGSMA, J. & MEURS, H. (1994b). Relationships among allergen-induced early and late phase airway obstructions, bronchial hyperreactivity, and inflammation in conscious, unrestrained guinea pigs. J. Allergy Clin. Immunol., 93, 1021-1030.
34. SCHAPIRA, R.M., WIESSNER, J.H., MORRISEY, J.F., ALMAGRO, U.A. & NELIN, L.D. (1998). L-arginine uptake and metabolism by lung macrophages and neutrophils following intratracheal instillation of silica in vivo. Am. J. Respir. Cell Mol. Biol., 19, 308-315.
35. SEEDS, E.A. & PAGE, C.P. (2001). Heparin inhibits allergen-induced eosinophil infiltration into guinea-pig lung via a mechanism unrelated to its anticoagulant activity. Pulmon. Pharmacol. Ther., 14, 111-119.
36. 4. Allergy Asthma Proc., 24, 59-65.
37. UCHIDA, D.A., ACKERMAN, S.J., COYLE, A.J., LARSEN, G.L., WELLER, P.F., FREED, J. & IRVIN, C.G. (1993). The effect of human eosinophil granule major basic protein on airway responsiveness in the rat in vivo. A comparison with polycations. Am. Rev. Respir. Dis., 147, 982-988.
38. VAN AMSTERDAM, R.G., BROUWER, F. & ZAAGSMA, J. (1989). Analysis of the beta-adrenoceptor mediated inhibition of IgG1 and IgE dependent guinea-pig anaphylactic tracheal smooth muscle contraction. Agents Actions, 26, 48-51.
39. WARDLAW, A.J., DUNNETTE, S., GLEICH, G.J., COLLINS, J.C. & KAY, A. (1988). Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Am. Rev. Respir. Dis., 137, 62-69.
40. WHITE, S.R., KULP, G.V.P., SPAETHE, S.M., VAN ALSTYNE, E. & LEFF, A.R. (1991). A kinetic assay for eosinophil peroxidase activity in eosinophils and eosinophil conditioned media. J. Immunol. Methods, 44, 257-263.
41. YAHATA, T., NISHIMURA, Y., MAEDA, H. & YOKOYAMA, M. (2002). Modulation of airway responsiveness by anionic and cationic polyelectrolyte substances. Eur. J. Pharmacol., 434, 71-79.